# Effect of Nebulized and Intravenous Hypertonic Saline 3% on the Management of Patients With Acute Respiratory Distress Syndrome

> **NCT06226402** · NA · UNKNOWN · sponsor: **Tanta University** · enrollment: 105 (estimated)

## Conditions studied

- Nebulization
- Hypertonic Saline
- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Hypertonic saline 3% nebulizer
- **DRUG:** Intravenous hypertonic saline 3%

## Key facts

- **NCT ID:** NCT06226402
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2024-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06226402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06226402, "Effect of Nebulized and Intravenous Hypertonic Saline 3% on the Management of Patients With Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06226402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*